<VariationArchive VariationID="982088" VariationName="NM_000088.4(COL1A1):c.459del (p.Gly154fs)" VariationType="Deletion" Accession="VCV000982088" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2020-10-25" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="970242" VariationID="982088">
      <GeneList>
        <Gene Symbol="COL1A1" FullName="collagen type I alpha 1 chain" GeneID="1277" HGNC_ID="HGNC:2197" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="50184101" stop="50201631" display_start="50184101" display_stop="50201631" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="48261456" stop="48278999" display_start="48261456" display_stop="48278999" Strand="-" />
          </Location>
          <OMIM>120150</OMIM>
          <Haploinsufficiency last_evaluated="2012-08-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL1A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-08-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL1A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000088.4(COL1A1):c.459del (p.Gly154fs)</Name>
      <CanonicalSPDI>NC_000017.11:50199237:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="50199238" stop="50199238" display_start="50199238" display_stop="50199238" variantLength="1" positionVCF="50199237" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="48276599" stop="48276599" display_start="48276599" display_stop="48276599" variantLength="1" positionVCF="48276598" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>G154fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.48276599del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.48276599del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.50199238del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.50199238del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007400.1" sequenceAccession="NG_007400" sequenceVersion="1" change="g.7402del">
            <Expression>NG_007400.1:g.7402del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000088.4" sequenceAccession="NM_000088" sequenceVersion="4" change="c.459del" MANESelect="true">
            <Expression>NM_000088.4:c.459del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000079.2" sequenceAccession="NP_000079" sequenceVersion="2" change="p.Gly154fs">
            <Expression>NP_000079.2:p.Gly154fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1" sequenceAccession="LRG_1">
            <Expression>LRG_1:g.7402del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1t1" sequenceAccession="LRG_1t1">
            <Expression>LRG_1t1:c.459del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="72667017" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000088.4(COL1A1):c.459del (p.Gly154fs) AND multiple conditions" Accession="RCV001261594" Version="1">
        <ClassifiedConditionList TraitSetID="55935">
          <ClassifiedCondition DB="MedGen" ID="C0268362">Osteogenesis imperfecta type III</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268363">Osteogenesis imperfecta with normal sclerae, dominant form</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000088.4(COL1A1):c.459del (p.Gly154fs) AND Osteogenesis imperfecta type I" Accession="RCV003517320" Version="1">
        <ClassifiedConditionList TraitSetID="5688">
          <ClassifiedCondition DB="MedGen" ID="C0023931">Osteogenesis imperfecta type I</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-05" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-10-25" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15024745</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7942841</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9295084</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9443882</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="55935" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3328" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 4</ElementValue>
                <XRef ID="MONDO:0008148" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OSTEOGENESIS IMPERFECTA, TYPE IV, WITH DENTINOGENESIS IMPERFECTA</ElementValue>
                <XRef Type="Allelic variant" ID="120160.0036" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta with normal sclerae, dominant form</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+type+4/5459" DB="Genetic Alliance" />
                <XRef ID="205497004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis Imperfecta Type IV</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with normal sclerae</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type IV</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">COL1A1</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">OI4</ElementValue>
                <XRef Type="MIM" ID="166220" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8696" />
                <XRef ID="8696" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).</Attribute>
                <XRef ID="NBK1295" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301472</ID>
                <ID Source="BookShelf">NBK1295</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <XRef ID="216820" DB="Orphanet" />
              <XRef ID="666" DB="Orphanet" />
              <XRef ID="C0268363" DB="MedGen" />
              <XRef ID="MONDO:0008148" DB="MONDO" />
              <XRef Type="MIM" ID="166220" DB="OMIM" />
            </Trait>
            <Trait ID="3679" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 3</ElementValue>
                <XRef ID="MONDO:0009804" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta, progressively deforming with normal sclerae</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type III</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta type III</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+type+3/5458" DB="Genetic Alliance" />
                <XRef ID="385483009" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">COL1A1</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">OI3</ElementValue>
                <XRef Type="MIM" ID="259420" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8695" />
                <XRef ID="8695" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).</Attribute>
                <XRef ID="NBK1295" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301472</ID>
                <ID Source="BookShelf">NBK1295</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_OsteogenesisImperfecta.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Osteogenesis imperfecta (OI)</CitationText>
              </Citation>
              <XRef ID="216812" DB="Orphanet" />
              <XRef ID="666" DB="Orphanet" />
              <XRef ID="C0268362" DB="MedGen" />
              <XRef ID="MONDO:0009804" DB="MONDO" />
              <XRef Type="MIM" ID="259420" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5688" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5697" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 1</ElementValue>
                <XRef ID="MONDO:0008146" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 1A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with opalescent teeth</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type 1A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 1 with dentinogenesis imperfecta</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI, TYPE I</ElementValue>
                <XRef Type="MIM" ID="166200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lobstein disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lobstein's Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta type I</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+type+1/5454" DB="Genetic Alliance" />
                <XRef ID="385482004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta tarda</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with blue sclerae</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OI1</ElementValue>
                <XRef Type="MIM" ID="166200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).</Attribute>
                <XRef ID="NBK1295" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000260571" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332445" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525779" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000562498" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512698" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561718" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511197" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521190" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8694" />
                <XRef ID="8694" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301472</ID>
                <ID Source="BookShelf">NBK1295</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_OsteogenesisImperfecta.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Osteogenesis imperfecta (OI)</CitationText>
              </Citation>
              <XRef ID="216796" DB="Orphanet" />
              <XRef ID="666" DB="Orphanet" />
              <XRef ID="C0023931" DB="MedGen" />
              <XRef ID="MONDO:0008146" DB="MONDO" />
              <XRef Type="MIM" ID="166200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2841554" SubmissionDate="2020-05-26" DateLastUpdated="2020-10-25" DateCreated="2020-10-25">
        <ClinVarSubmissionID localKey="NM_000088.3:c.459delT|OMIM:259420;166220" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001438867" DateUpdated="2020-10-25" DateCreated="2020-10-25" Type="SCV" Version="1" SubmitterName="Pathology and Clinical Laboratory Medicine, King Fahad Medical City" OrgID="506801" OrganizationCategory="laboratory" OrgAbbreviation="KFMC" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ofqy0osx/acmg_guidelines_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Arab</Ethnicity>
              <GeographicOrigin>Middle East</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL1A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000088.3:c.459delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="259420" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="166220" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5091399</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7983130" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4944517|MedGen:C0023931" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004297484" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15024745</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7942841</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9295084</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9443882</ID>
          </Citation>
          <Comment>This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with osteogenesis imperfecta (PMID: 15024745). ClinVar contains an entry for this variant (Variation ID: 982088). For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Gly154Alafs*111) in the COL1A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL1A1 are known to be pathogenic (PMID: 7942841, 9295084, 9443882).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL1A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.48276599del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0023931" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7983130" TraitType="Disease" MappingType="XRef" MappingValue="C0023931" MappingRef="MedGen">
        <MedGen CUI="C0023931" Name="Osteogenesis imperfecta type I" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2841554" TraitType="Disease" MappingType="XRef" MappingValue="166220" MappingRef="OMIM">
        <MedGen CUI="C0268363" Name="Osteogenesis imperfecta with normal sclerae, dominant form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2841554" TraitType="Disease" MappingType="XRef" MappingValue="259420" MappingRef="OMIM">
        <MedGen CUI="C0268362" Name="Osteogenesis imperfecta type III" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

